National rectal cancer intensity-modulated radiotherapy (IMRT) guidance - coming soon

For information only

With the use of intensity-modulated radiotherapy (IMRT) for rectal cancer increasing globally, the RCR will shortly be publishing guidance for the use of IMRT/VMAT radiotherapy for rectal cancer in the UK.

The guidance will address the multiple considerations when introducing routine IMRT. These include:

  • Considerations for pre-treatment investigations
  • Patient preparation
  • Optimal delineation of gross tumour volume (GTV)/clinical target volume (CTV)/planning target volume (PTV)
  • Provision of a standard atlas for delineation of lymph nodes
  • Strategies for delivery of a simultaneous integrated boost (SIB), IMRT planning and patient set-up and treatment verification.

Guidance is expected in January 2021.

Please notify me when the guidance is published